We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

End of the roadshow

12 March 2020 By Alec Macfarlane

Oodles of time and money is spent sending executives and bankers around the world to sell stock. China’s InnoCare Pharma is doing things differently, by marketing its Hong Kong IPO virtually. With balance sheets and carbon footprints in focus, the model may last beyond Covid-19.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)